This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 52/2/373    most recent HYPERTENSIONAHA.108.114199v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fava, C. Articles by Melander, O. Search for Related Content PubMed PubMed Citation Articles by Fava, C. Articles by Melander, O. Related Collections Cerebrovascular disease/stroke Other hypertension Genetics of Stroke Genetics of cardiovascular disease

(Hypertension. 2008;52:373.)
© 2008 American Heart Association, Inc.

Original Articles

The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure

Cristiano Fava; Martina Montagnana; Peter Almgren; Lena Rosberg; Giuseppe Lippi; Bo Hedblad; Gunnar Engström; Göran Berglund; Pietro Minuz; Olle Melander

From the Department of Clinical Sciences (C.F., M.M., P.A., L.R., B.H., G.E., G.B., O.M.), Lund University, University Hospital of Malmö, Malmö, Sweden; and the Departments of Biomedical and Surgical Sciences (C.F., P.M.) and Morphological-Biomedical Sciences (M.M., G.L.), University Hospital of Verona, Verona, Italy.

Correspondence to Cristiano Fava, Department of Biomedical and Surgical Sciences, Division of Internal Medicine C, Piazza LA Scuro 10, 37134 Verona, Italy. E-mail cristiano.fava{at}med.lu.se

Cytochrome (CYP) 4A11 and CYP4F2 are responsible for renal production of 20-hydroxyeicosatetraenoic acid, a vasoconstrictor and natriuretic substance. The CYP4A11 F434S and CYP4F2 V433M polymorphisms reduce 20-hydroxyeicosatetraenoic acid production in vitro. The aim of the present study was to evaluate the effect of these polymorphisms on blood pressure (BP) levels, hypertension prevalence, and risk of incident cardiovascular events in middle-aged Swedes. The polymorphisms were genotyped in the cardiovascular cohort of the Malmö Diet and Cancer Study. The incidence of cardiovascular events (coronary events, n=276; ischemic stroke, n=199) was monitored over 10 years of follow-up. The analysis of BP levels was performed twice: either excluding or including subjects under antihypertensive treatment. In the whole population, CYP4A11 S434S homozygotes had higher systolic BP, both crude and adjusted for the number of antihypertensive drugs, and higher prevalence of hypertension with respect to F434 carriers. Male, but not female, CYP4F2 M433 carriers had significantly higher crude and adjusted systolic and diastolic BPs and a trend toward higher hypertension prevalence (P=0.06) with respect to V433V homozygotes. After adjustment for major cardiovascular risk factors, the hazard ratio for incident ischemic stroke in male CYP4F2 M433 carriers was significantly higher with respect to V433V homozygotes (hazard ratio: 1.69; 95% CI: 1.10 to 2.60) even when baseline BP levels and hypertension prevalence were included in the Cox proportional hazard model. A common CYP4F2 V433M polymorphism might increase the risk of incident ischemic stroke in male subjects only partially through its elevating effect on BP. Additional studies are needed to confirm these data.

Key Words: cytochrome P450 • 20-HETE • hypertension • stroke • genetics

This article has been cited by other articles:

				J. H.Y. Wu, J. M. Hodgson, M. W. Clarke, A. P. Indrawan, A. E. Barden, I. B. Puddey, and K. D. Croft Inhibition of 20-Hydroxyeicosatetraenoic Acid Synthesis Using Specific Plant Lignans: In Vitro and Human Studies Hypertension, November 1, 2009; 54(5): 1151 - 1158. [Abstract] [Full Text] [PDF]

				V. Perez-Andreu, V. Roldan, A. I. Anton, N. Garcia-Barbera, J. Corral, V. Vicente, and R. Gonzalez-Conejero Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy Blood, May 14, 2009; 113(20): 4977 - 4979. [Abstract] [Full Text] [PDF]